Opioid Use Disorder Statistics in Montana

Comprehensive Opioid Use Disorder statistics for Montana, including prevalence, demographics, treatment access, and outcomes data.

4 min read
35%[1]
Increase in Opioid Overdose Deaths in Montana

Between 2014 and 2023, the number of deaths from opioid overdoses rose by approximately 35%, highlighting the escalating severity of the crisis in the state.

2014-2023

Key Takeaways

  • An estimated 3.2% of adults in Montana have experienced Opioid Use Disorder in the past year, indicating a significant public health challenge.3.2%[2]
  • A substantial treatment gap exists, with an estimated 70% of Montanans diagnosed with OUD not receiving any form of treatment.70%[3]
  • The state's opioid overdose death rate nearly doubled in less than a decade, rising from 10.2 to 22.5 per 100,000 people between 2014 and 2023.22.5 per 100k[1]
  • Access to care is limited, as Montana has half the national average of buprenorphine-waivered physicians available to prescribe medication-assisted treatment.5 per 100k[2]
  • Disparities are evident, with Native American populations experiencing OUD rates as high as 5.6%, significantly above the state average.5.6%[2]
  • Rural areas are disproportionately affected, with an OUD prevalence rate of 6.8% compared to urban centers.6.8%[4]

The Scale of the Opioid Crisis in Montana

Opioid Use Disorder (OUD) represents one of the most pressing public health crises in Montana, mirroring a national trend but with unique local characteristics. Nationally, 5.7 million people had an opioid use disorder in 2023[5]. In Montana, various surveys and data sources indicate that thousands of residents are affected. Understanding the prevalence of OUD is the first step in grasping the scope of the issue and developing effective strategies for prevention, treatment, and recovery.

The data reveals a consistent and concerning picture of OUD's impact across different age groups and time periods within the state. These statistics are not just numbers; they represent individuals, families, and communities grappling with the consequences of addiction.

OUD Prevalence in Montana

7.2%[1]
Of adults aged 18-65 had OUD in a 2023 statewide survey
2023
5.2%[1]
Statewide OUD prevalence rate among adults in 2022
2022
3.1%[2]
Of adults aged 18-25 with OUD in the past year
2023
3.6%[6]
Of adults aged 25-54 with OUD in the past year
2022

Co-Occurring Mental Health Conditions

Opioid Use Disorder rarely exists in isolation. Many individuals with OUD in Montana also contend with co-occurring mental health disorders, such as depression and anxiety[2]. This overlap complicates treatment and recovery, as both conditions must be addressed simultaneously for the best outcomes. For example, adolescents with a past-year major depressive episode are significantly more likely to engage in opioid misuse[5]. The broader mental health landscape in Montana provides critical context for the OUD crisis.

Mental Health Context in Montana

Of adults experienced any mental illness in a 12-month period
National Alliance on Mental Illness (2021)
22%[7]
Of residents were affected by major depressive disorder
Substance Abuse and Mental Health Services Administration (2022)
8%[8]
Of residents were affected by anxiety disorders
Substance Abuse and Mental Health Services Administration (2022)
10%[8]
Of the adult population reported having a serious mental illness
National Alliance on Mental Illness (2021)
4%[7]

Demographics and Disparities

The burden of Opioid Use Disorder is not distributed evenly across Montana's population. Certain demographic groups face a higher risk due to a combination of socioeconomic factors, historical trauma, and unequal access to resources. Data shows significant disparities based on gender, race, and geography. For instance, males account for a majority of both OUD cases (65%)[6] and opioid overdose fatalities (65%)[1]. Furthermore, rural populations are particularly vulnerable due to factors like longer emergency response times and limited healthcare access[1].

OUD Prevalence Disparities in Montana

Prevalence by Gender
3.8%
Men
2.5%
Women
Men have a 52% higher prevalence rate than women.
Men in Montana show a significantly higher rate of OUD compared to women.
Prevalence by Race/Ethnicity
5.6%
Native Americans
3.5%
White Adults
Native American populations have a 60% higher prevalence rate.
Racial disparities are stark, with Native American communities facing a disproportionately high burden of OUD.
Prevalence by Geography
6.8%
Rural Areas
3.9%
Urban Centers
Rural residents have a 74% higher prevalence rate.
The opioid crisis is particularly acute in Montana's rural communities, which face unique challenges in accessing care.

The Treatment Gap: Challenges in Accessing Care

Despite the high prevalence of OUD, a significant portion of affected individuals in Montana do not receive the care they need. This treatment gap is a critical issue, with various reports indicating that anywhere from 30% to only 45% of those with OUD receive any form of treatment in a given year[4][2]. Barriers such as geographic isolation, stigma, and long travel distances to facilities contribute to why many Montanans do not receive timely care[4]. Even for those with insurance coverage, accessing services remains a challenge.

Treatment Utilization Statistics

40%[6]
Of individuals with OUD received medication-assisted treatment (MAT) in 2023
2023
50%[6]
Of Medicaid beneficiaries with OUD access treatment services
2023
85%[6]
Of OUD treatment costs are covered by Montana Medicaid
2023

Provider Shortages and Systemic Barriers

A primary driver of the treatment gap is a severe shortage of qualified healthcare professionals. The entire state of Montana is designated as a mental health Health Professional Shortage Area (HPSA)[9]. This limited provider density correlates with longer wait times and reduced opportunities for early intervention[4]. When compared to national averages, Montana lags significantly in the availability of OUD treatment facilities and specialized providers, further compounding the challenge for residents seeking help.

Healthcare Provider Density: Montana vs. National Average

Buprenorphine-Waivered Physicians (per 100k)
10
National Average
5
Montana
Montana has 50% fewer buprenorphine prescribers than the national average.
This shortage directly limits access to Medication-Assisted Treatment (MAT), a gold standard for OUD care.
OUD Treatment Facilities (per 100k)
3.5
National Average
0.8
Montana
Montana has 77% fewer OUD treatment facilities per capita.
The lack of facilities means longer travel times and fewer options for comprehensive treatment programs.
Psychiatrists (per 10k)
1
National Average
0.5
Montana
Montana has half the density of psychiatrists compared to the U.S. average.
This shortage impacts the ability to treat co-occurring mental health disorders that often accompany OUD.
Changes in survey methodologies for the 2023 National Survey on Drug Use and Health (NSDUH), particularly for substance use treatment questions, limit direct comparisons of some metrics with pre-2022 data.

Economic and Systemic Factors

The opioid crisis is not only a health issue but also an economic one. Untreated OUD leads to increased healthcare costs and lost productivity, straining public resources and community resilience[10]. Systemic factors like economic decline in rural areas and pervasive stigma further exacerbate the situation[11]. Montana's investment in mental health services lags behind the national average, with the state ranking 40th in funding per capita[11]. However, there are positive signs, as funding for opioid treatment programs in Montana increased by approximately 15% from 2022 to 2023[2].

Frequently Asked Questions

Sources & References

All statistics and claims on this page are supported by peer-reviewed research and official government data sources.

1[PDF] Drug Overdose Deaths in Montana 2014-2023 - dphhs. Dphhs. Published 2023. Accessed January 2026. https://dphhs.mt.gov/assets/publichealth/EMSTS/Data/DrugOverdoseDeaths_2014-2023.pdf
2[PDF] MONTANA - National Survey on Drug Use and Health - SAMHSA. Substance Abuse and Mental Health Services Administration. Published 2022. Accessed January 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt56188/2023-nsduh-sae-state-tables_0/2023-nsduh-sae-state-tabs-montana.pdf
3Montana Drug and Alcohol Statistics - Methadone.org. Methadone. Published 2002. Accessed January 2026. https://www.methadone.org/drugs/montana-drug-alcohol-statistics/
4[PDF] Montana Opioid Summary - National Institute on Drug Abuse. Nida. Published 2015. Accessed January 2026. https://nida.nih.gov/sites/default/files/21967-montana-opioid-summary.pdf
5Key Substance Use and Mental Health Indicators in the United States. Substance Abuse and Mental Health Services Administration. Published 2023. Accessed January 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt47095/National%20Report/National%20Report/2023-nsduh-annual-national.htm
6[PDF] Opioid Use in Montana - dphhs. Dphhs. Published 2023. Accessed January 2026. https://dphhs.mt.gov/assets/publichealth/EMSTS/Data/Opioids_1pager.pdf
7In F. M ental H ealth in M ontana. National Alliance on Mental Illness. Published 2021. Accessed January 2026. https://www.nami.org/wp-content/uploads/2023/07/MontanaStateFactSheet.pdf
8Montana 2023 Uniform Reporting System Mental Health .... Substance Abuse and Mental Health Services Administration. Published 2022. Accessed January 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt53129/Montana.pdf
9Prevalence Ranking | Mental Health .... Mhanational. Accessed January 2026. https://mhanational.org/the-state-of-mental-health-in-america/data-rankings/prevalence-data/
10Opioid Use/Misuse in Older Adults - Montana State University. Montana. Published 2021. Accessed January 2026. https://www.montana.edu/extension/health/opioid_resources/opioid_fact_sheet.html
11[PDF] Montana Substance Use Disorders Task Force Strategic Plan - dphhs. Dphhs. Accessed January 2026. https://dphhs.mt.gov/assets/publichealth/EMSTS/opioids/MontanaSubstanceUseDisordersTaskForceStrategicPlan.pdf